MMR cut mumps hard after a grimace-named childhood virus
Mumps is a contagious paramyxovirus illness of humans alone, usually opening with fever and malaise before painful parotid swelling. Without shots it clustered in crowded childhood; live vaccines from the 1970s, packaged as MMR, drove case counts down wherever programs stuck.
Droplets, saliva, and close contact spread the RNA virus; people can infect others from about a week before swelling through several days after. Supportive rest and pain relief are the mainstay because infection is usually self-limited once immunity clears it. Rare complications include deafness and inflammation of testes, ovaries, breasts, pancreas, meninges, or brain—testicular involvement can lower fertility and, rarely, cause sterility. Unvaccinated infection peaks at ages five to nine; illness hits males more often and adolescents and adults harder, with temperate winters and springs busiest.
The English word appears around 1600 from mump, a grimace or mutter, matching swollen faces and painful swallowing. Chinese records may reach 640 BC; Hippocrates described a Thasos outbreak near 410 BC. British physician Robert Hamilton gave a modern scientific account in 1790. The virus was isolated in 1945; a short-lived killed vaccine arrived in 1948 before live attenuated shots replaced it. Maurice Hilleman’s work folded mumps with measles and rubella; MMR-2 won U.S. approval in 1971, and two-dose schedules spread in the 1980s.
U.S. vaccination began in the 1960s. Global incidence from 1977 to 1985 averaged 290 cases per 100,000 yearly where tracked; U.S. cases fell ninety-seven percent from 1968 to 1982, and Finland later reported near-elimination. Japan dropped MMR from its national schedule in 1993 over Urabe-strain meningitis worries and saw cases rebound. Large twenty-first-century waves include more than 300,000 Chinese cases in 2013 and over 56,000 in England and Wales in 2004–2005, concentrated in college-age cohorts touched by earlier vaccine scares.
Source: Mumps
